Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
- PMID: 18502302
- DOI: 10.1016/S0140-6736(08)60765-5
Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study
Abstract
Background: Finland has the highest incidence of type 1 diabetes worldwide, reaching 40 per 100,000 people per year in the 1990s. Our aim was to assess the temporal trend in type 1 diabetes incidence since 2000 in Finnish children aged younger than 15 years and to predict the number of cases of type 1 diabetes in the future.
Methods: Children with newly diagnosed type 1 diabetes in Finland who were listed on the National Public Health Institute diabetes register, Central Drug Register, and Hospital Discharge Register in 1980-2005 were included in a cohort study. We excluded patients with type 2 diabetes and diabetes occurring secondary to other conditions, such as steroid use, Down's syndrome, and congenital malformations of pancreas.
Findings: 10,737 children-5816 boys and 4921 girls-were diagnosed with type 1 diabetes before 15 years of age during 1980-2005. The average age-standardised incidence was 42.9 per 100,000 per year (95% CI 42.6-44.3) during this period, increasing from 31.4 per 100,000 per year in 1980 to 64.2 per 100,000 per year in 2005. The age-specific rates per 100,000 per year were 31.0, 50.5, and 50.6 at ages 0-4 years, 5-9 years, and 10-14-years, respectively. We noted a significant non-linear component to the time trend (p<0.0003). In children aged 0-4 years, the increase was largest, at 4.7% more affected every year. The overall boy-to-girl ratio of incidence was 1.1; at the age of 13 years, it was 1.7 (1.4-2.0). The predicted cumulative number of new cases with type 1 diabetes before 15 years of age between 2006 and 2020 was about 10 800.
Interpretation: The incidence of type 1 diabetes in Finnish children is increasing even faster than before. The number of new cases diagnosed at or before 14 years of age will double in the next 15 years and the age of onset will be younger (0-4 years).
Comment in
-
Halting the accelerating epidemic of type 1 diabetes.Lancet. 2008 May 24;371(9626):1730-1. doi: 10.1016/S0140-6736(08)60739-4. Lancet. 2008. PMID: 18502281 No abstract available.
Similar articles
-
Incidence data of childhood-onset type I diabetes in France during 1988-1997: the case for a shift toward younger age at onset.Pediatr Res. 2002 Dec;52(6):859-62. doi: 10.1203/00006450-200212000-00008. Pediatr Res. 2002. PMID: 12438661
-
The rising incidence of childhood type 1 diabetes in New South Wales, 1990-2002.Med J Aust. 2005 Sep 5;183(5):243-6. Med J Aust. 2005. PMID: 16138797
-
["Constantly rising or peaks and plateaus?" Incidence of childhood type 1 diabetes in Hungary (1989-2009)].Orv Hetil. 2011 Oct 16;152(42):1692-7. doi: 10.1556/OH.2011.29210. Orv Hetil. 2011. PMID: 21979222 Review. Hungarian.
-
Australia's national trends in the incidence of Type 1 diabetes in 0-14-year-olds, 2000-2006.Diabet Med. 2009 Jun;26(6):596-601. doi: 10.1111/j.1464-5491.2009.02737.x. Diabet Med. 2009. PMID: 19538234
-
Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden.Curr Diabetes Rev. 2013 Jul;9(4):342-9. doi: 10.2174/15733998113099990064. Curr Diabetes Rev. 2013. PMID: 23721159 Review.
Cited by
-
Age at onset of type 1 diabetes in parents and recurrence risk in offspring.Diabetes. 2010 Jan;59(1):210-4. doi: 10.2337/db09-0344. Epub 2009 Oct 15. Diabetes. 2010. PMID: 19833881 Free PMC article.
-
Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.Diabetes. 2009 Dec;58(12):2835-42. doi: 10.2337/db08-1305. Epub 2009 Sep 15. Diabetes. 2009. PMID: 19755526 Free PMC article.
-
Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1 Diabetes.J Clin Endocrinol Metab. 2019 Jun 1;104(6):2277-2285. doi: 10.1210/jc.2018-02094. J Clin Endocrinol Metab. 2019. PMID: 30657906 Free PMC article.
-
Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study.Diabetes Ther. 2022 Aug;13(8):1531-1546. doi: 10.1007/s13300-022-01285-1. Epub 2022 Jul 2. Diabetes Ther. 2022. PMID: 35779209 Free PMC article.
-
Increased resistin serum concentrations in patientswith type 1 diabetes mellitus.J Clin Res Pediatr Endocrinol. 2013 Sep 10;5(3):189-93. doi: 10.4274/Jcrpe.1072. J Clin Res Pediatr Endocrinol. 2013. PMID: 24072088 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical